Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4655597 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL6554404 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL28744275 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL4557947 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL28995100 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL23270390 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL20225052 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL10045699 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL4263417 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 | |
| SCHEMBL11131660 | 1.00 | OPRM1 (0.46) | OPRM1LMNATSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104655828-B | System, the method and apparatus of diagnosis based on tissue | 加州大学评议会 | 2018-04-27 | — | — | CN | claimed |
| CN-107049957-A | The nano particle of encapsulating is prepared plant-scale | 伊休蒂卡有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-106727477-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106727424-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | claimed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | claimed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | claimed |
| EP-1959938-B1 | MATRIX-CONTROLLED TRANSDERMAL SYSTEM COMPRISING SALTS OF ACE INHIBITOR DICARBOXYLIC ACIDS | HEXAL AG (DE) | 2011-04-27 | — | — | EP | claimed |
| EP-1789508-B1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INT (FR) | 2010-06-23 | — | — | EP | claimed |
| EP-1789508-A1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-05-30 | — | — | EP | claimed |
| WO-2006021698-A1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2006-03-02 | — | — | WO | claimed |
| EP-1100465-B1 | MEDICINAL AEROSOL FORMULATIONS | JAGO RES AG (CH) | 2004-11-24 | — | — | EP | claimed |
| CN-104655828-B | System, the method and apparatus of diagnosis based on tissue | 加州大学评议会 | 2018-04-27 | — | — | CN | disclosed |
| CN-107049957-A | The nano particle of encapsulating is prepared plant-scale | 伊休蒂卡有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-106727477-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106727424-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-1279165-C | Influenza vaccine compositions | SMITHKLINE BEECHAM FARMA (DE) | 2006-10-11 | — | — | CN | disclosed |
| CN-1254541-C | Novel compounds | SMITHKLINE BEECHAM BIOLOG (BE) | 2006-05-03 | — | — | CN | disclosed |
| WO-2006021698-A1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2006-03-02 | — | — | WO | disclosed |
| CN-1533434-A | Influenza vaccine compositions | ʷ��˿�������ȳ�ķҩƷ���Ϲ�˾���� | 2004-09-29 | — | — | CN | disclosed |
| CN-1426421-A | Tumor specific animal proteins | SMITHKLINE BEECHAM BIOLOG (BE) | 2003-06-25 | — | — | CN | disclosed |